Southend residents face a stark reality as they grapple with the Mounjaro weight loss jab. While approximately 3.4 million people nationwide meet the eligibility criteria for this drug, the NHS plans to treat a mere 220,000 individuals over a three-year period. This disparity highlights a critical issue: the NHS's limited resources and the potential exclusion of those in need. But here's where it gets controversial: the NHS's incentive for GP surgeries to prescribe the drug. Ministers have confirmed that practices will receive a £3,000 bonus for prescribing Mounjaro. However, this bonus may not significantly impact the number of eligible patients, as a typical GP practice of 6,000 patients will have fewer than 20 individuals qualifying for the drug in total. The funding for year one is expected to cover only a fraction of that number. The situation is particularly dire in Southend, where the Lib Dems highlight some of the country's starkest health divides. Male life expectancy in the most and least wealthy areas differs by a staggering 10.5 years. Obesity, a key contributing factor, exacerbates this issue. Yet, many residents cannot afford private healthcare or prescriptions, which can cost between £160 and £310 per month. This leaves them with limited options for managing their health and weight, further widening the health gap.
